SOFTMEDX (00648) controlling shareholder intends to reduce its stake by up to 20.8%

SOFTMEDX(00648) announced that its controlling shareholder, Multi Omniverse Group Limited, entered into a placement agreement with a placement agent on May 7, 2026 (after trading hours) to sell up to 445 million shares of the company, equivalent to 20.8% of the total issued shares of the company. The placement price per share is HK$0.11 and the placement period is from the date of the agreement to May 15, 2026, or a longer period as agreed in writing between the placement agent and the shareholder. Upon completion of the placement and assuming all placed shares are successfully sold to subscribers, the shareholder will hold 648 million shares of the company, equivalent to 30.3% of the total issued shares, and will continue to be the controlling shareholder. The placement shareholder has also notified the company that it currently has no plans to further sell its shares in the company after the placement.